Advantages of Using the Net-Benefit Approach for Analysing Uncertainty in Economic Evaluation Studies
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 21 (1) , 39-48
- https://doi.org/10.2165/00019053-200321010-00003
Abstract
No consensus has yet been reached on how to analyse uncertainty in economic evaluation studies where individual patient data are available for costs and health effects. This paper summarises the...Keywords
This publication has 28 references indexed in Scilit:
- The Design and Analysis of Stochastic Cost-Effectiveness Studies for the Evaluation of Health Care InterventionsDrug Information Journal, 2001
- Incremental net benefit in randomized clinical trialsStatistics in Medicine, 2001
- Representing Both First- and Second-order Uncertainties by Monte Carlo Simulation for Groups of PatientsMedical Decision Making, 2000
- Power and Sample Size in Cost- Effectiveness AnalysisMedical Decision Making, 1999
- The cost-effectiveness of lipid lowering in patients with diabetes: results from the 4S trialDiabetologia, 1999
- Is It Really So Bad to be Unambiguously Ineificient?Medical Decision Making, 1999
- Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40BMJ, 1998
- Uncertainty in Decision Models Analyzing Cost-EffectivenessMedical Decision Making, 1998
- Confidence intervals for cost/effectiveness ratiosHealth Economics, 1995
- Costs, effects and C/E‐ratios alongside a clinical trialHealth Economics, 1994